Bronchiectasis, characterized by chronic airway inflammation and structural lung damage, is increasingly recognized as having systemic consequences beyond the respiratory system. The persistent ...

Panelists discuss how evaluating potential causes of bronchiectasis is important despite many cases being idiopathic, as identifying treatable traits can lead to specific interventions, such as CFTR ...

Mark Metersky, MD, FCCP, illustrates the pathology of bronchiectasis. This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on bronchiectasis. Bronchiectasis is an ...

Bronchiectasis is a chronic suppurative lung disease that is characterized by permanent bronchial dilatation and recurrent respiratory symptoms. Bronchiectasis could be a debilitating disease and ...

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (NASDAQ:ARDM) (the “Company”) today announced the upcoming presentation of research at the European Respiratory Society (ERS) 2017 Annual Congress ...

This activity is provided by National Jewish Health. Bronchiectasis is a complex and increasingly prevalent condition often overlooked in clinical practice, with frequent overlap with other ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Swallow function was evaluated using three scoring ...

Non–cystic fibrosis bronchiectasis (NCFB) is a chronic inflammatory condition of the lungs associated with respiratory infections and daily cough and sputum. Non-cystic fibrosis bronchiectasis. Image ...

In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from ...